Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziresovir vs placebo in RSV bronchiolitis in infants
CTR20240557Phase 3Completed
- Sponsor
- Aicobio
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ziresovir in respiratory syncytial virus disease (RSV), bronchiolitis, sponsored by Aicobio. Started Mar 2024; status: completed.
02
Drugs
ziresovir
03
Conditions
respiratory syncytial virus disease (RSV)bronchiolitis
Beyond the preview
Go deeper on CTR20240557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240557.